Community/Retail

The FDA has expanded the indication of the antiepileptic drug perampanel (FYCOMPA®, Eisai) CIII for monotherapy and adjunctive use in pediatric patients aged 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures.

Get involved this October and show your appreciation for the work pharmacists do.

Dacomitinib tablets (Vizimpro, Pfizer) received FDA approval for the first-line treatment of patients with metastatic non-small cell lung cancer.

The FDA has approved Eli Lilly’s preventive migraine treatment galcanezumab-gnlm (Emgality).

Pregnant women take herbal and natural products (HNPs) as alternatives to prescription medications, but, HNPs have active ingredients and drug interactions that can potentially cause harm to both the mother and her baby.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A Mississippi nurse practioner and former family clinic owner was sentenced to 42 months in prison and ordered to pay more than $1 million in restitution for her role in a health care benefits fraud scheme.

A generic version of Cialis® (tadalafil, Eli Lilly) tablets (2.5 mg, 5 mg, 10 mg, 20 mg) for the United States market has been annouced by Teva Pharmaceuticals

National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses.

Unprecedented in scale, the AMR Challenge charges pharmaceutical and health insurance companies, food animal producers and purchasers, medical professionals, government health officials, and other industry leaders from around the world to work together to address antibiotic resistance.

Inconsistency of insurance policy coverage, unaffordability, and difficulty accessing vaccine providers were found to be key barriers for adult immunization in a recent study by UCLA Center for Health Policy researchers.

The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program.

The CLL/SLL indication is a standard approval and the follicular lymphoma indication is an accelerated approval contingent on the results of a confirmatory trial

World Pharmacists Day is being celebrated Tuesday around the globe.

A pharmacy owner facing an indictment charging her with submitting millions of dollars in fraudulent claims to Medicare and Medicaid is expected to be arraigned today in federal court in Brooklyn, New York.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

A federal appropriations bill will not include bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.

What's the best advice for a patient who is interested in a vaccine against shingles?

A coalition of health care industry leaders hosted a meeting Thursday in Washington, DC, to examine how to address this problem.

Mylan’s new Dalfampridine Extended-Release Tablets, 10 mg, an authorized generic version of Acorda's Ampyra® is being marketed to treat adult patients with multiple sclerosis.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Health, United States, 2017 includes an in-depth special feature that discusses mortality in America.

The social media post noted that grief counselors will be made available to associates and "will remain available as long as they are needed."

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data.

In this clip, Troy Trygstad, Editor in Chief of Pharmacy Times, interviews Jack Vallandinham, the owner of Jack’s Corner Drug Store in Sigourney, Iowa. Jack explains how he works with other health care providers and gets to know patient needs in order to provide them with optimal care.

A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.

Implementation of universal health care is part of the Sustainable Development Goals (SDGs), which are new targets signed by 193 United Nations member states to improve health and development by 2030.